<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T22:55:24Z</responseDate>
  <request identifier="oai:figshare.com:article/34027503" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34027503</identifier>
        <datestamp>2026-09-29T20:01:53Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Clinical characteristics associated with FABP5 expression in HCC.&lt;/p&gt;</dc:title>
          <dc:creator>Rui An (636731)</dc:creator>
          <dc:creator>Shibing Hou (2288815)</dc:creator>
          <dc:creator>Min Hong (279203)</dc:creator>
          <dc:creator>Jiaorong Zhen (23973891)</dc:creator>
          <dc:creator>Zhijuan Wang (1900771)</dc:creator>
          <dc:creator>Haoming Huang (12791303)</dc:creator>
          <dc:creator>Weixuan Zhao (12058148)</dc:creator>
          <dc:creator>Mianmian Liao (10916520)</dc:creator>
          <dc:creator>Weiqu Yuan (23973893)</dc:creator>
          <dc:creator>Danping Huang (196661)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>xlink "&gt; tcga</dc:subject>
          <dc:subject>predicted worse survival</dc:subject>
          <dc:subject>independent prognostic factor</dc:subject>
          <dc:subject>experimental validation confirmed</dc:subject>
          <dc:subject>nf -&amp;# 954</dc:subject>
          <dc:subject>epithelial &amp;# 8211</dc:subject>
          <dc:subject>protein &amp;# 8211</dc:subject>
          <dc:subject>xlink "&gt; fabp5</dc:subject>
          <dc:subject>fabp5 correlated positively</dc:subject>
          <dc:subject>immune checkpoint profiles</dc:subject>
          <dc:subject>higher tide scores</dc:subject>
          <dc:subject>b &amp;# 945</dc:subject>
          <dc:subject>b &amp;# 8211</dc:subject>
          <dc:subject>b pathway genes</dc:subject>
          <dc:subject>identify potential fabp5</dc:subject>
          <dc:subject>characterize fabp5 expression</dc:subject>
          <dc:subject>duplicate md simulations</dc:subject>
          <dc:subject>fabp5 drives pd</dc:subject>
          <dc:subject>hcc cell proliferation</dc:subject>
          <dc:subject>&amp;# 954</dc:subject>
          <dc:subject>tide scores</dc:subject>
          <dc:subject>b pathway</dc:subject>
          <dc:subject>therapeutic potential</dc:subject>
          <dc:subject>protein docking</dc:subject>
          <dc:subject>decreased expression</dc:subject>
          <dc:subject>cell rna</dc:subject>
          <dc:subject>promising fabp5</dc:subject>
          <dc:subject>fabp5 shapes</dc:subject>
          <dc:subject>fabp5 regulates</dc:subject>
          <dc:subject>fabp5 knockdown</dc:subject>
          <dc:subject>vitro assays</dc:subject>
          <dc:subject>targeting compound</dc:subject>
          <dc:subject>significantly upregulated</dc:subject>
          <dc:subject>seq datasets</dc:subject>
          <dc:subject>related pathways</dc:subject>
          <dc:subject>regulatory role</dc:subject>
          <dc:subject>molecular dynamics</dc:subject>
          <dc:subject>molecular docking</dc:subject>
          <dc:subject>mesenchymal transition</dc:subject>
          <dc:subject>lipid metabolism</dc:subject>
          <dc:subject>l1 via</dc:subject>
          <dc:subject>l1 upregulation</dc:subject>
          <dc:subject>l1 axis</dc:subject>
          <dc:subject>immunosuppressive microenvironment</dc:subject>
          <dc:description>&lt;p&gt;(A) Distribution of FABP5 expression across different age groups. (B) FABP5 expression levels in patients stratified by race. (C) Association of FABP5 expression with tumor grade. (D) Sankey diagram summarizing relationships among FABP5 expression, patient survival status, tumor grade, race, and age. (E) TP53 mutation frequency was significantly higher in patients with high FABP5 expression compared with those with low expression. G1: Group 1 (High Expression); G2: Group 2 (Low Expression).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T20:01:47Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0356359.g003</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Clinical_characteristics_associated_with_FABP5_expression_in_HCC_p_/34027503</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
